Clinical Trial Update: Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety, efficacy, and pharmacokinetics of tamibarotene in patients with relapsed or refractory acute promyelocytic leukemia has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Tamibarotene (tamibarotene)

Snippet

Sponsor: CytRx | Conditions: Acute Promyelocytic Leukemia | Phase 2 | Status: COMPLETED